Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment-Reference-Cited by-同舟云学术

Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment

Published:2021-03-03 Issue:1 Volume:18 Page:13-18
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Le Brian H¹²^ORCID,Aggarwal Ghauri³,Douglas Carol⁴,Green Michael²⁵⁶,Nicoll Amanda⁷,Ahmedzai Sam⁸

Affiliation:

1. The Royal Melbourne Hospital Parkville Integrated Palliative Care Service Victoria Australia

2. Department of Medicine The University of Melbourne Victoria Australia

3. Concord Hospital Concord Centre for Palliative Care New South Wales Australia

4. Royal Brisbane and Women's Hospital Health Service Palliative Care Queensland Australia

5. Sunshine Hospital, Medical Oncology Victoria Australia

6. Peter MacCallum Cancer Centre Medical Oncology Melbourne Victoria Australia

7. Box Hill Hospital Gastroenterology Victoria Australia

8. The University of Sheffield Oncology, Western Bank Sheffield UK

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13561

Reference52 articles.

1. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis

2. Cancer pain management: Opioid analgesics, part 2;Wickham RJ;J Adv Pract Oncol,2017

3. Opioids for cancer pain – An overview of Cochrane reviews;Wiffen PJ;Cochrane Database Syst Rev,2017

4. Pharmacology of Opioids and their Effects on Gastrointestinal Function

5. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Severe Cancer Pain with Oxycodone/Naloxone Treatment: A Literature Review Update;Journal of Personalized Medicine;2024-05-01

2. Opioid toxicity after oxycodone/naloxone to oxycodone conversion: case series;BMJ Supportive & Palliative Care;2024-02-26

3. Pre-emptive use of prolonged release oxycodone/naloxone combo significantly reduces postoperative pain after total hip arthroplasty;Anaesthesia, Pain & Intensive Care;2023-07-24

4. No pain, no strain: Targin® mitigates pain and constipation following spinal cord injury;Annals of Clinical and Translational Neurology;2023-01-24

5. ENhANCE trial protocol: A multi-centre, randomised, phase IV trial comparing the efficacy of oxycodone/naloxone prolonged release (OXN PR) versus oxycodone prolonged release (Oxy PR) tablets in patients with advanced cancer;Contemporary Clinical Trials Communications;2022-12